Work
Health economics, outcomes research and policy: my thesis, projects and professional updates.
-
Is pirtobrutinib cost-effective for relapsed or refractory CLL in the Netherlands?
MSc thesis summary: a cost-effectiveness analysis following Dutch ZIN guidelines.